Loading
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Mar 2017 for Veracyte, INC., €1,489.
Insider track record
Disclosed buys
4
Disclosed sells
0
Signal history
Closed purchases
Market purchases
4
Positive at T+90
0%
Median T+90
-40.6%
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -24.9%Entry US$12.56 · Close at T+365 US$9.43
- -18.5%Entry US$14.67 · Close at T+365 US$11.96
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Julie Brooks: trading record in brief
This profile gathers the share dealings of Julie Brooks across 2 companies, led by Conceptus Inc and Veracyte, Inc. We count 15 filings; the first trade dates from 14 March 2011 and the latest from 31 January 2017.
Purchases make up the whole of the open-market record (4 purchases, €33k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 9 share grants.
Half of the purchases are above €11k and half below. After 4 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -40.6%. This is a record of the past, not a forecast.
On 6 March 2017 came the latest disclosure, a share grant for €1,489 in Veracyte, Inc. The last insider purchase was made public on 30 July 2014, 4,468 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Julie Brooks
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
377 shares@ US$4.2334.2% of flowCommon StockSEC:0001384101-17-000020:0
382 shares@ US$4.2133.3% of flowCommon StockSEC:0001628280-16-018301:0
281 shares@ US$5.5132.5% of flowCommon StockSEC:0001104659-16-102273:0
1,000 shares@ US$14.71Common StockSEC:0001104659-14-054951:0
Canonical exit: 26 Oct 2014 (T+90)
122 shares@ US$14.54Common StockSEC:0001104659-14-054951:1
Canonical exit: 27 Oct 2014 (T+90)
1,000 shares@ US$14.00Common StockSEC:0001104659-14-052998:0
Canonical exit: 19 Oct 2014 (T+90)
1,000 shares@ US$14.36Common StockSEC:0001104659-14-052998:1
Canonical exit: 20 Oct 2014 (T+90)
6,923 shares@ US$31.00Common StockSEC:0001179110-13-009974:0
22,575 shares@ US$31.00Common StockSEC:0001179110-13-009974:1
366 shares@ US$23.50Common StockSEC:0001179110-13-005352:0
11,200 shares0Common StockSEC:0001179110-13-002412:0
12,500 shares0Common StockSEC:0001179110-12-003784:0
4,000 shares0CommonSEC:0001179110-11-005038:0
13 of 13 declarations
